Welcome to our dedicated page for Clearday news (Ticker: CLRD), a resource for investors and traders seeking the latest updates and insights on Clearday stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Clearday's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Clearday's position in the market.
Clearday (CLRD:OTC EXMKT), a tech-centric healthcare services company, has provided an update on its business combination with Viveon Healthcare Acquisition (VHAQ:OTC EXMKT). The company has developed software and digital assistants for the Senior Living sector, delivering therapies and engagement via tablets, smartTVs, and companion robotics. Both companies are working towards completing the combination, which includes listing the combined company's stock on NASDAQ or NYSE American.
Clearday's CEO, James Walesa, acknowledged the challenging financing environment but reaffirmed the company's commitment to the deal. He emphasized that Clearday stockholders will receive shares in the combined company on a pro-rata basis, independent of Clearday's current stock value. The company is also taking steps to complete SEC filings to allow trading on the Pink OTC Market.
Clearday (OTC: CLRD) aligns with the Office of Disease Prevention and Health Promotion to support National Health Observances (NHOs), focusing on Alzheimer's Disease and brain health in June. CEO Jim Walesa emphasized Clearday’s commitment to brain health year-round through innovative technologies for caregivers. The company will host related programs in Texas and Florida and release a series of press updates detailing Clearday’s role in dementia care, innovations, and future visions. Stakeholders are encouraged to follow these updates on Clearday’s website.
Clearday announces the resignation of Board Member Jeff Coleman, thanking him for his service since 2021. The company plans to add a new director to support the Business Combination with Viveon Healthcare Acquisition Corp, focusing on advancements in Digital Assistants and aging applications to drive new revenue streams.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Clearday (CLRD)?
What is the market cap of Clearday (CLRD)?
